Astra Gets Chinese Firm’s Lung Cancer Drug In $1.5 Billion Deal

Astra Gets Chinese Firm’s Lung Cancer Drug In $1.5 Billion Deal — Bloomberg

OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns